Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)

CNY 14.38

(0.0%)

Market Cap (In CNY)

1.77 Billion

Revenue (In CNY)

134.59 Million

Net Income (In CNY)

-70.99 Million

Avg. Volume

997.16 Thousand

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.36-31.55
PE
-
EPS
-
Beta Value
0.274
ISIN
CNE100004NR4
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jun Yu
Employee Count
-
Website
https://www.gdkbio.com
Ipo Date
2021-08-02
Details
Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.